NSEGeneral Updates2d ago · 28 Aug 2026, 09:03 pm
General Updates
Gujarat Themis Biosyn Limited · GUJTHEM
✦ AI SummaryFundraise
Gujarat Themis Biosyn Limited has informed the Exchange about the closure of QIP Issue, with the Fund-Raising Committee approving and declaring the closure of issue period for the QIP at Rs. 354 per Equity Share, including a premium of Rs. 353 per Equity Share.
Analysis Scores
Earnings Impact2/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gujarat Themis Biosyn Limited has informed the Exchange about the closure of QIP Issue.
Attachments (1)
📄pdf
Download →
GUJARATTHEMIS_28082026210332_Outcome28082026.pdf
View document text
GUJARAT THEMIS
BIOSYN LIMITED
CIN: L24230GJ1981PLC004878
REGD. OFFICE & FACTORY: 69/C GIDC INDUSTRIAL ESTATE,
VAPI – 396 195, DIST. VALSAD, GUJARAT, INDIA
TEL: 0260-2430027 / 2400639, E-mail: hrm@gtbl.in.net
August 28, 2026
Listing Department Department of Corporate Services
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, C-1, Block-G Phiroze Jeejeebhoy Towers, Dalal Street
Bandra Kurla Complex Mumbai - 400001
Bandra East, Mumbai 400051
Symbol: GUJTHEM Scrip Code: 506879
Dear Sir/Madam,
Re: Qualified institutions placement (“QIP” or “Issue”) of equity shares of face value of
Rs. 1 each (the “Equity Shares”) to qualified institutional buyers (“QIBs”)
Sub: Outcome of the meeting of the Fund-Raising Committee.
Further to our intimation dated August 25, 2026 in respect of the proposed QIP, we wish to inform
you that the Fund-Raising Committee of the Company has at its meeting today, i.e. August 28,
2026, inter alia, passed the following resolutions:
(i) approving and declaring the closure of issue period for the QIP today, i.e. August 28, 2026,
pursuant to the receipt of application forms and the funds in the escrow account from the
eligible qualified institutional buyers in accordance with the terms of the Issue;
(ii) determining and approving the issue price for 2,11,86,440 Equity Shares to be allotted to
eligible QIBs at a price of Rs. 354 per Equity Share, including a premium of Rs. 353 per
Equity Share, which takes into account a discount of Rs. 18.57 per Equity Share on the
floor price of Rs. 372.57 per Equity Share (4.98% of the floor price), as permitted in terms
of Regulation 176(1) of Chapter VI of the Securities and Exchange Board of India (Issue
of Capital and Disclosure Requirements) Regulations, 2018, as amended.
(iii) approving and finalizing the confirmation of allocation note for sending to such QIBs to
whom the allocation of Equity Shares pursuant to the QIP, is to be confirmed.
(iv) approving and adopting the placement document dated August 28, 2026 in connection with
the QIP. Copy of the same is being also made available on the website of the Company at
www.gtbl.in
In this relation we are filing the placement document with your office.
The Fund-Raising Committee meeting commenced at 8:15 p.m. and the meeting was concluded at
8:30 p.m.
GUJARAT THEMIS
BIOSYN LIMITED
The QIP was opened on August 25, 2026 and the same was intimated to you pursuant to our letter
dated August 25, 2026.
We request you to take the above on record pursuant to compliance under SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, as amended.
Copy of this intimation is being also made available on the website of the Company at
www.gtbl.in.
Thanking you
Yours faithfully
For Gujarat Themis Biosyn Limited
Vineet Gawankar
Company Secretary & Compliance Officer